Worse outcomes and higher costs of care in fibrostenotic Crohn’s disease: a real-world propensity-matched analysis in the USA
Background Patients with Crohn’s disease (CD) may develop fibrostenotic strictures. No currently available therapies prevent or treat fibrostenotic CD (FCD), making this a critical unmet need.Aim To compare health outcomes and resource utilisation between CD patients with and without fibrostenotic d...
Saved in:
| Main Authors: | K T Park, Florian Rieder, Gabriel Wong, Cindy Kin, Melody Dehghan, Edward Neuberger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/8/1/e000781.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serological assessment of PRO-C16 (type XVI collagen formation) reflects intestinal fibrostenotic strictures in patients with crohn’s disease
by: Joachim H. Mortensen, et al.
Published: (2025-08-01) -
Endoscopic Dilation for Fibrostenotic Complications in Eosinophilic Esophagitis—A Narrative Review
by: Marco Michelon, et al.
Published: (2025-05-01) -
For Better or Worse
by: Sinenhlanhla Sithulisiwe Chisale
Published: (2016-07-01) -
Worse survival and higher rates of relapse in U.S. Armenians with papillary thyroid cancer
by: Karen Tsai, et al.
Published: (2024-12-01) -
Postural instability and falls are more frequent in Parkinson’s disease patients with worse trunk mobility
by: Nathalie Ribeiro Artigas, et al.
Published: (2016-07-01)